UTSW, InterAct partner on novel gene therapy for metastatic cancer
March 24, 2026
March 24, 2026
DALLAS, Texas, March 24 -- The University of Texas Southwestern Medical Center posted the following news release:
* * *
UTSW, InterAct partner on novel gene therapy for metastatic cancer
UT Southwestern Medical Center and InterAct Therapeutics have announced an exclusive licensing agreement to develop and commercialize a groundbreaking computational platform and gene therapy pipeline targeting cancer metastasis.
The partnership centers on Inte . . .
* * *
UTSW, InterAct partner on novel gene therapy for metastatic cancer
UT Southwestern Medical Center and InterAct Therapeutics have announced an exclusive licensing agreement to develop and commercialize a groundbreaking computational platform and gene therapy pipeline targeting cancer metastasis.
The partnership centers on Inte . . .
